| 000 | 01386 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513125611.0 | ||
| 264 | 0 | _c19971017 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGlover, J M | |
| 245 | 0 | 0 |
_aPhase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302). _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cSep 1997 |
||
| 300 |
_a1173-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOligodeoxyribonucleotides, Antisense |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xadverse effects |
| 650 | 0 | 4 | _aPhosphorothioate Oligonucleotides |
| 650 | 0 | 4 |
_aThionucleotides _xadverse effects |
| 700 | 1 | _aLeeds, J M | |
| 700 | 1 | _aMant, T G | |
| 700 | 1 | _aAmin, D | |
| 700 | 1 | _aKisner, D L | |
| 700 | 1 | _aZuckerman, J E | |
| 700 | 1 | _aGeary, R S | |
| 700 | 1 | _aLevin, A A | |
| 700 | 1 | _aShanahan, W R | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 282 _gno. 3 _gp. 1173-80 |
|
| 999 |
_c9294136 _d9294136 |
||